Stefan Beyer joined Vibalogics in 2006 as Director of Corporate and Business Development, back when the company was operating as BioProtect Research. Not long after the company was renamed Vibalogics, and Stefan was appointed CEO in early 2008, and then President in 2020 and in 2022 takes forward responsibilities as Managing Director.
Under Stefan’s leadership, Vibalogics has grown considerably, acquiring new clients across the globe. He has also played a vital role in nurturing client relationships over the years, helping to build long-standing and loyal partnerships with customers including some of the world’s largest biopharma companies, to start-ups and university research teams.
Before joining Vibalogics, Stefan worked at Scil Proteins as Business Development Manager. He gained his PhD in 1996 and studied Microbiology, Biotechnology and Molecular Genetics at the University of Münster.